Cancé company information, Employees & Contact Information

Eligibility criteria for lung cancer screening in France: a modelling study The Lancet

Centre for Cancer Drug Discovery The Institute of Cancer Research

Recent News about Night Shift Work and Cancer: What Does it Mean for Workers? Centers for Disease Control and Prevention | CDC (.gov)

Mirvetuximab Soravtansine-Gynx Approved for Ovarian Cancer National Cancer Institute (.gov)

Global cancer burden growing, amidst mounting need for services World Health Organization (WHO)

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer The New England Journal of Medicine

In vivo dendritic cell reprogramming for cancer immunotherapy Science | AAAS

Monitoring the impact of COVID-19 in France on cancer care: a differentiated impact Nature

Cancer World Health Organization (WHO)

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer The New England Journal of Medicine

SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer Nature

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer The New England Journal of Medicine

Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge Nature

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer The New England Journal of Medicine

A framework for advancing our understanding of cancer-associated fibroblasts Nature

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer The New England Journal of Medicine

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer The New England Journal of Medicine

Olaparib for Metastatic Castration-Resistant Prostate Cancer The New England Journal of Medicine

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer The New England Journal of Medicine

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer The New England Journal of Medicine

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer The New England Journal of Medicine

Alcohol is one of the biggest risk factors for breast cancer World Health Organization (WHO)

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer The New England Journal of Medicine

Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer The New England Journal of Medicine

Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer The New England Journal of Medicine

Relay For Life | Cancer Walk American Cancer Society

Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes | British Journal of Cancer Nature

Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer The New England Journal of Medicine

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer The New England Journal of Medicine

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer The New England Journal of Medicine

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer The New England Journal of Medicine

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer The New England Journal of Medicine

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis The New England Journal of Medicine

Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer The New England Journal of Medicine

Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients The New England Journal of Medicine

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation The New England Journal of Medicine

Smart nanoparticles for cancer therapy - Signal Transduction and Targeted Therapy Nature

Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer The New England Journal of Medicine

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer The New England Journal of Medicine

Imaging biomarker roadmap for cancer studies Nature

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer The New England Journal of Medicine

Number of Pregnancies Influences Breast Cancer Risk for Women with BRCA Mutations Columbia University Mailman School of Public Health

Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer The New England Journal of Medicine

Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer The New England Journal of Medicine

Association analyses identify 31 new risk loci for colorectal cancer susceptibility Nature

18F-FDG PET/CT for Staging and Restaging of Breast Cancer Journal of Nuclear Medicine

Key steps for effective breast cancer prevention Nature

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer The New England Journal of Medicine

Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer Nature

Too Many Older Men Are Still Screened for Prostate Cancer (Published 2023) The New York Times

A Randomized Trial of Laparoscopic versus Open Surgery for Rectal Cancer The New England Journal of Medicine

Access to inpatient palliative care among cancer patients in France: an analysis based on the national cancer cohort BMC Health Services Research

Lung cancer risk assessment for workers exposed to polycyclic aromatic hydrocarbons in various industries ScienceDirect.com

Oral sex is now the leading risk factor for throat cancer The Conversation

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma The New England Journal of Medicine

Alcohol rehabilitation and cancer risk: a nationwide hospital cohort study in France The Lancet

A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention The New England Journal of Medicine

Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study The BMJ

Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer The New England Journal of Medicine

Exemestane for Breast-Cancer Prevention in Postmenopausal Women The New England Journal of Medicine

The cancer patient who inspired French movement to block reintroduction of pesticide | France The Guardian

Guidelines for the welfare and use of animals in cancer research Nature

Cancer heterogeneity: implications for targeted therapeutics Nature

Genomic basis for RNA alterations in cancer Nature

The dying officer treated for cancer with baking soda BBC

Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer The New England Journal of Medicine

Redefining lung cancer care with early intervention and personalized treatment Inquirer.net

Cancer survivor Fr. Jerry Orbos shares journey to healing CBCPNews

Fr. Jerry Orbos on battling lung cancer: ‘Focus on the humor, not the tumor’ Philstar.com

"After I was diagnosed with cancer I could better understand the suffering of those who are sick" - Fr Martin Micallef TVMnews.mt